ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
Daniel103
|
1.3K |
565K |
15 |
02/08/23 |
02/08/23 |
ASX - By Stock
|
1.3K
|
565K
|
15
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Daniel103
|
18K |
7.0M |
0 |
25/07/23 |
25/07/23 |
ASX - By Stock
|
18K
|
7.0M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Second Quarter Results Presentation
|
|
Daniel103
|
117 |
30K |
6 |
28/02/23 |
28/02/23 |
ASX - By Stock
|
117
|
30K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Submits New Information to FDA IND File for SR-aGVHD
|
|
Daniel103
|
576 |
207K |
5 |
03/10/22 |
03/10/22 |
ASX - By Stock
|
576
|
207K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on Novartis Agreement
|
|
Daniel103
|
850 |
256K |
11 |
14/12/21 |
14/12/21 |
ASX - By Stock
|
850
|
256K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Corporate Update Webcast
|
|
Daniel103
|
115 |
35K |
8 |
20/05/21 |
20/05/21 |
ASX - By Stock
|
115
|
35K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
10% up and big volume
|
|
Daniel103
|
42 |
15K |
6 |
17/05/21 |
17/05/21 |
ASX - By Stock
|
42
|
15K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
Daniel103
|
5.8K |
2.9M |
1 |
15/05/21 |
15/05/21 |
ASX - By Stock
|
5.8K
|
2.9M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: COVID ARDS Trial Topline 60-Day Results
|
|
Daniel103
|
1.6K |
468K |
7 |
12/05/21 |
12/05/21 |
ASX - By Stock
|
1.6K
|
468K
|
7
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
Daniel103
|
10K |
3.0M |
1 |
05/05/21 |
05/05/21 |
ASX - By Stock
|
10K
|
3.0M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Daniel103
|
18K |
7.0M |
5 |
21/04/21 |
21/04/21 |
ASX - By Stock
|
18K
|
7.0M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Poll, do we have any medical professionals.
|
|
Daniel103
|
165 |
39K |
0 |
07/04/21 |
07/04/21 |
ASX - By Stock
|
165
|
39K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Poll, do we have any medical professionals.
|
|
Daniel103
|
165 |
39K |
0 |
06/04/21 |
06/04/21 |
ASX - By Stock
|
165
|
39K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Daniel103
|
18K |
7.0M |
9 |
28/03/21 |
28/03/21 |
ASX - By Stock
|
18K
|
7.0M
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Low Back Pain Results
|
|
Daniel103
|
1.1K |
319K |
18 |
26/03/21 |
26/03/21 |
ASX - By Stock
|
1.1K
|
319K
|
18
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Low Back Pain Results
|
|
Daniel103
|
1.1K |
319K |
3 |
25/03/21 |
25/03/21 |
ASX - By Stock
|
1.1K
|
319K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
Daniel103
|
5.8K |
2.9M |
0 |
16/03/21 |
16/03/21 |
ASX - By Stock
|
5.8K
|
2.9M
|
0
|
|
Charts
|
MSB |
Re:
MSB Charts
|
|
Daniel103
|
888 |
649K |
0 |
14/03/21 |
14/03/21 |
Charts
|
888
|
649K
|
0
|
|
Charts
|
MSB |
Re:
MSB Charts
|
|
Daniel103
|
888 |
649K |
1 |
14/03/21 |
14/03/21 |
Charts
|
888
|
649K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
The investment case FOR Mesoblast
|
|
Daniel103
|
422 |
147K |
9 |
08/03/21 |
08/03/21 |
ASX - By Stock
|
422
|
147K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Corporate Update and Financial Results Webcast
|
|
Daniel103
|
51 |
19K |
3 |
20/11/20 |
20/11/20 |
ASX - By Stock
|
51
|
19K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Advisory Committee Sets Review Date for Remestemcel-L
|
|
Daniel103
|
854 |
434K |
0 |
25/09/20 |
25/09/20 |
ASX - By Stock
|
854
|
434K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: DSMB Recommends Continuation of Phase 3 COVID-19 Trial
|
|
Daniel103
|
299 |
141K |
4 |
04/09/20 |
04/09/20 |
ASX - By Stock
|
299
|
141K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: DSMB Recommends Continuation of Phase 3 COVID-19 Trial
|
|
Daniel103
|
299 |
141K |
3 |
04/09/20 |
04/09/20 |
ASX - By Stock
|
299
|
141K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Daniel103
|
20 |
8.2K |
1 |
02/09/20 |
02/09/20 |
ASX - By Stock
|
20
|
8.2K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Emergency Use Authorization and other approvals
|
|
Daniel103
|
67 |
37K |
5 |
30/08/20 |
30/08/20 |
ASX - By Stock
|
67
|
37K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: EAP for Remestemcel-L in Children with MIS-C due to COVID-19
|
|
Daniel103
|
425 |
193K |
16 |
26/08/20 |
26/08/20 |
ASX - By Stock
|
425
|
193K
|
16
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Daniel103
|
18K |
7.0M |
1 |
23/08/20 |
23/08/20 |
ASX - By Stock
|
18K
|
7.0M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Daniel103
|
54 |
21K |
1 |
21/08/20 |
21/08/20 |
ASX - By Stock
|
54
|
21K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MESO action tonight
|
|
Daniel103
|
3.1K |
1.4M |
3 |
18/08/20 |
18/08/20 |
ASX - By Stock
|
3.1K
|
1.4M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
MESO action tonight
|
|
Daniel103
|
3.1K |
1.4M |
9 |
18/08/20 |
18/08/20 |
ASX - By Stock
|
3.1K
|
1.4M
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Daniel103
|
18K |
7.0M |
5 |
17/08/20 |
17/08/20 |
ASX - By Stock
|
18K
|
7.0M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
MESO action tonight
|
|
Daniel103
|
3.1K |
1.4M |
1 |
14/08/20 |
14/08/20 |
ASX - By Stock
|
3.1K
|
1.4M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ryoncil: ODAC/FDA Meeting Discussion
|
|
Daniel103
|
2.0K |
699K |
15 |
14/08/20 |
14/08/20 |
ASX - By Stock
|
2.0K
|
699K
|
15
|
|
ASX - By Stock
|
MSB |
Re:
ODAC Session Live Chat
|
|
Daniel103
|
50 |
16K |
1 |
13/08/20 |
13/08/20 |
ASX - By Stock
|
50
|
16K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
FDA ODAC Meeting Material discussion analysis
|
|
Daniel103
|
491 |
194K |
1 |
12/08/20 |
12/08/20 |
ASX - By Stock
|
491
|
194K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
FDA ODAC Meeting Material discussion analysis
|
|
Daniel103
|
491 |
194K |
1 |
12/08/20 |
12/08/20 |
ASX - By Stock
|
491
|
194K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
FDA ODAC Meeting Material discussion analysis
|
|
Daniel103
|
491 |
194K |
4 |
12/08/20 |
12/08/20 |
ASX - By Stock
|
491
|
194K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Advisory Committee Sets Review Date for Remestemcel-L
|
|
Daniel103
|
854 |
434K |
13 |
11/08/20 |
11/08/20 |
ASX - By Stock
|
854
|
434K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
MESO action tonight
|
|
Daniel103
|
3.1K |
1.4M |
3 |
11/08/20 |
11/08/20 |
ASX - By Stock
|
3.1K
|
1.4M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
MESO action tonight
|
|
Daniel103
|
3.1K |
1.4M |
7 |
11/08/20 |
11/08/20 |
ASX - By Stock
|
3.1K
|
1.4M
|
7
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB - Most exciting 6 months
|
|
Daniel103
|
729 |
375K |
8 |
09/08/20 |
09/08/20 |
ASX - By Stock
|
729
|
375K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading - Aug 2020 on
|
|
Daniel103
|
2.3K |
919K |
0 |
07/08/20 |
07/08/20 |
ASX - By Stock
|
2.3K
|
919K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Daniel103
|
13 |
7.2K |
4 |
07/08/20 |
07/08/20 |
ASX - By Stock
|
13
|
7.2K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Advisory Committee Sets Review Date for Remestemcel-L
|
|
Daniel103
|
854 |
434K |
1 |
06/08/20 |
06/08/20 |
ASX - By Stock
|
854
|
434K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
Daniel103
|
5.8K |
2.9M |
4 |
04/08/20 |
04/08/20 |
ASX - By Stock
|
5.8K
|
2.9M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
MESO action tonight
|
|
Daniel103
|
3.1K |
1.4M |
5 |
04/08/20 |
04/08/20 |
ASX - By Stock
|
3.1K
|
1.4M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Daniel103
|
18K |
7.0M |
0 |
30/07/20 |
30/07/20 |
ASX - By Stock
|
18K
|
7.0M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Daniel103
|
18K |
7.0M |
29 |
27/07/20 |
27/07/20 |
ASX - By Stock
|
18K
|
7.0M
|
29
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Expands Executive Leadership Team
|
|
Daniel103
|
170 |
80K |
5 |
24/07/20 |
24/07/20 |
ASX - By Stock
|
170
|
80K
|
5
|
|